Plasma Cell Neoplasm
📧 Sign up to get email alerts when something new happens for Plasma Cell Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial of isotretinoin plus dexamethasone for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating interferon alfa after chemotherapy and peripheral stem cell transplantation in patients with Stage III or …
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer [Phase 1]
A Phase 1 clinical trial update reports completion of arsenic trioxide in patients with advanced hematologic cancers, including leukemia and…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
This is a Phase 2 clinical trial update evaluating bevacizumab with or without thalidomide in relapsed or refractory multiple myeloma; the s…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Interleukin-12 in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating interleukin-12 in patients with multiple myeloma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma [Phase 2]
Phase 2 trial update evaluating melphalan and filgrastim to stimulate peripheral stem cell collection in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: PS-341 in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial update of PS-341 (bortezomib) in hematologic cancers; the study has completed and includes leukemia, lymphoma, multiple myelom…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma [Phase 3]
This is an update on a Phase 3 trial evaluating combination chemotherapy for stage II/III multiple myeloma that has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma [Phase 2]
Bryostatin-1 was studied in patients with relapsed multiple myeloma. The Phase 2 study has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan
This clinical trial update indicates the study NCT00602147, investigating genetic mutations related to mucositis in multiple myeloma patient…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma [Phase 2]
This Phase 2 trial evaluated thalidomide, doxorubicin, and dexamethasone in patients with untreated stage II or stage III multiple myeloma, …
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial of AE-941 for relapsed or refractory Multiple Myeloma has been completed, reported by AEterna Zentaris.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1]
Phase 1 trial of panobinostat in combination with everolimus for relapsed or refractory lymphoma or multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Tipifarnib in Treating Patients With Advanced Hematologic Cancer [Phase 1]
This document reports the status of a Phase 1 clinical trial of tipifarnib for advanced hematologic cancers sponsored by the National Cancer…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders [Phase 1]
A Phase 1 trial evaluating paricalcitol with zoledronate in relapsed or refractory multiple myeloma and other plasma cell disorders was term…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant [Phase 2]
Phase 2 clinical trial evaluating reduction of immunosuppression plus interferon alfa and chemotherapy for post-transplant malignant tumors;…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update describing a conditioning regimen of melphalan, fludarabine, and alemtuzumab followed by peripheral stem cell …
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis [Phase 2]
A Phase 2 clinical trial evaluating 4'-Iodo-4'-Deoxydoxorubicin in patients with AL amyloidosis and related plasma cell neoplasms has comple…
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer [Phase 2]
Phase 2 trial evaluating epoetin alfa for treating chemotherapy-induced anemia in cancer patients; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer [NA]
A clinical trial update reports completion of a donor stem cell transplant study in older or frail patients with hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer [Phase 2]
Phase 2 trial evaluating early administration of anti-thymocyte globulin (ATG) followed by cyclophosphamide, busulfan and fludarabine as a c…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 3]
Phase 3 trial evaluating melphalan followed by peripheral stem cell transplantation in patients with multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating tocladesine for recurrent or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial of a combination including arsenic trioxide, thalidomide, dexamethasone, and ascorbic acid for relapsed or refractory multip…
-
CLINICAL_TRIALS trial_result · 2011-12-26Clinical Trial Update: Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 trial evaluating sorafenib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma has terminated with results p…